Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes

By Li W.M.   Dragowska W.H.   Bally M.B.   Schutze-Redelmeier M.-P.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3319-3329

Elsevier

Access to resources Recommend Favorite

Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes

By Frank F.M.   Petray P.B.   Cazorla S.I.   Munoz M.C.   Corral R.S.   Malchiodi E.L.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 77-86

Elsevier

Access to resources Recommend Favorite

Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

By Lingnau K.   Egyed A.   Schellack C.   Mattner F.   Buschle M.   Schmidt W.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3498-3508

Elsevier

Access to resources Recommend Favorite

CpG motifs as immune adjuvants

By Klinman D.M.   Barnhart K.M.   Conover J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Immune effects and mechanisms of action of CpG motifs

By Krieg A.M.  

Vaccine, Vol. 19, Iss. 6, 2000-11 ,pp. : 618-622

Elsevier

Access to resources Recommend Favorite